Skip to content

Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee

Clinical Outcome Study for the Triathlon CR Total Knee

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02535741
Acronym
TriathlonCR
Enrollment
168
Registered
2015-08-31
Start date
2006-10-31
Completion date
2016-05-31
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Keywords

Knee Replacement, Arthroplasty

Brief summary

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System.

Detailed description

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System. The primary objective of this study will be to compare the active range of motion values for the Triathlon CR Total Knee System with those of the Scorpio CR Total Knee System, a historical control group. ROM values will be measured by use of a Goniometer according to the protocol. It is expected that the Triathlon CR Total Knee System group's range of motion is not 5 degrees worse or superior to the control group's range of motion at two-years.

Interventions

DEVICETriathlon CR Total Knee System

Primary total knee replacement

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients willing to sign the Ethic Commission approved, study specific Informed Patient Consent Form. 2. Patients willing and able to comply with scheduled postoperative clinical and radiographic evaluations and rehabilitation. 3. Male or non-pregnant female between the ages of 21-80 years of age at the time of surgery. 4. Patients requiring a primary total knee replacement. 5. Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN). 6. Patients with intact collateral ligaments.

Exclusion criteria

1. Patients with inflammatory arthritis. 2. Patients that are morbidly obese, body mass index (BMI) \> 40. 3. Patients with a history of total / unicompartmental reconstruction of the affected joint. 4. Patients that have had a high tibial osteotomy or femoral osteotomy. 5. Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. 6. Patients with a systemic or metabolic disorder leading to progressive bone deterioration. 7. Patients that are immunologically compromised, or receiving chronic steroids (\>30 days duration). 8. Patients bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis. 9. Patients with a knee fusion to the affected joint. 10. Patients with an active or suspected latent infection in or about the knee joint. 11. Patients with a history of total joint replacement on the opposite knee within less than 1 year. 12. Patients requiring bilateral total knee replacement.

Design outcomes

Primary

MeasureTime frameDescription
Mean Triathlon CR Active Range of Motion (ROM)2 years follow-upComparison of the active ROM values for patients receiving the Triathlon CR Total Knee System with historical active ROM values of the Scorpio CR Total Knee System, a control group by literature review at 2 years post Total Knee Arthroplasty. See Chaudhary R, et al 2008 JBJS included for historical control data.

Secondary

MeasureTime frameDescription
Investigation of Patient Outcome With Radiographic AnalysisPre-operative, 3 months, 1, 2 and 5 years follow-upPlain radiographs will be obtained for assessment of fixation of the device.
Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-upThe Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, Range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as excellent, good, fair, or poor, a higher value represents a better outcome.
Investigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient QuestionnairePre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-upThe SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical (PSC) and mental status component (MCS) score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.
Investigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient QuestionnairePre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-upThe WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.

Countries

Denmark, Finland, Germany, Spain

Participant flow

Recruitment details

The first patient included in the study was enrolled in October 2006. 168 cases received the Triathlon CR knee system over a 56 month period in a consecutive manner in 6 centers.

Participants by arm

ArmCount
Triathlon CR Total Knee System
Progressive data: Primary total knee replacement
168
Total168

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event3
Overall StudyExclusion criteria: Bilateral implant4
Overall StudyLost to Follow-up10
Overall StudyMissing data6
Overall StudyWithdrawal by Subject9

Baseline characteristics

CharacteristicTriathlon CR Total Knee System
Age, Continuous66 years
STANDARD_DEVIATION 8.3
Range of Motion (ROM)107.21 degree
STANDARD_DEVIATION 12.5
Sex: Female, Male
Female
114 Participants
Sex: Female, Male
Male
54 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 168
serious
Total, serious adverse events
23 / 168

Outcome results

Primary

Mean Triathlon CR Active Range of Motion (ROM)

Comparison of the active ROM values for patients receiving the Triathlon CR Total Knee System with historical active ROM values of the Scorpio CR Total Knee System, a control group by literature review at 2 years post Total Knee Arthroplasty. See Chaudhary R, et al 2008 JBJS included for historical control data.

Time frame: 2 years follow-up

Population: Comparison to data from the literature was not done.

ArmMeasureValue (MEAN)Dispersion
Triathlon CR Total Knee SystemMean Triathlon CR Active Range of Motion (ROM)112.96 degreeStandard Deviation 13.708
Secondary

Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)

The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, Range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as excellent, good, fair, or poor, a higher value represents a better outcome.

Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

Population: The number included in the analysis in one or more rows differs from the overall number analysed because that data were not collected.

ArmMeasureGroupValue (MEAN)Dispersion
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Pain/Motion pre-operative38.2 units on a scaleStandard Deviation 21.7
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Pain/Motion 3 months75.2 units on a scaleStandard Deviation 15.4
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Pain/Motion 1 year81.7 units on a scaleStandard Deviation 13.8
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Pain/Motion 2 years86 units on a scaleStandard Deviation 11.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Pain/Motion 5 years88 units on a scaleStandard Deviation 9.7
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Function Score pre-operative58.9 units on a scaleStandard Deviation 14.2
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Function Score 3 months78.9 units on a scaleStandard Deviation 17.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Function Score 1 year82.2 units on a scaleStandard Deviation 18.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Function Score 2 years86.2 units on a scaleStandard Deviation 18
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)KSS Function Score 5 years81.5 units on a scaleStandard Deviation 20.5
Secondary

Investigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire

The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical (PSC) and mental status component (MCS) score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

Population: The number included in the analysis in one or more rows differs from the overall number analysed because that data were not collected.

ArmMeasureGroupValue (MEAN)Dispersion
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire3 years MCS51.4 units on a scaleStandard Deviation 11.3
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnairepre-operative PCS30.0 units on a scaleStandard Deviation 8.2
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire3 months PCS37.5 units on a scaleStandard Deviation 8.8
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire1 year PCS42.0 units on a scaleStandard Deviation 9.4
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire2 years PCS44.6 units on a scaleStandard Deviation 9.7
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire3 years PCS41.9 units on a scaleStandard Deviation 10.8
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire4 years PCS42.1 units on a scaleStandard Deviation 10.7
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire5 years PCS43.0 units on a scaleStandard Deviation 11.1
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnairepre-operative MCS47.5 units on a scaleStandard Deviation 13.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire3 months MCS50.7 units on a scaleStandard Deviation 10.8
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire1 year MCS52.2 units on a scaleStandard Deviation 9.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire2 years MCS50.8 units on a scaleStandard Deviation 10.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire4 years MCS50.7 units on a scaleStandard Deviation 10.5
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire5 years MCS53.9 units on a scaleStandard Deviation 10.3
Secondary

Investigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire

The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.

Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

Population: The number included in the analysis in one or more rows differs from the overall number analysed because that data were not collected.

ArmMeasureGroupValue (MEAN)Dispersion
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnairepre-operative total score166.42 units on a scaleStandard Deviation 60.88
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire3 months total score78.99 units on a scaleStandard Deviation 58.98
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire1 year total score45.04 units on a scaleStandard Deviation 47.14
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire2 years total score40.6 units on a scaleStandard Deviation 41.3
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire3 years total score46.28 units on a scaleStandard Deviation 51.02
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire4 years total score47.94 units on a scaleStandard Deviation 52.21
Triathlon CR Total Knee SystemInvestigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire5 years total score43.64 units on a scaleStandard Deviation 53.1
Secondary

Investigation of Patient Outcome With Radiographic Analysis

Plain radiographs will be obtained for assessment of fixation of the device.

Time frame: Pre-operative, 3 months, 1, 2 and 5 years follow-up

Population: Radiographic data were not collected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026